Ownership signal CIK-linked ownership evidence from parsed SEC filings. 2 signals
Large-stake signal

Form

SCHEDULE 13D/A

Active or control-oriented beneficial ownership filing.

Ownership

15%

Beneficial ownership of this reported class.

Shares

15,628,395 shares

Shares beneficially owned as disclosed.

Event date

09 Nov 2026

Date tied to the ownership event or amendment.

Accepted by SEC

12 Nov 2026

EDGAR acceptance date.

How to read this large-stake filing
  • Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
  • Compare this filing with the holder history and issuer page before treating the percentage as a current position.
  • Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Subject security Names, identifiers, and filing context for this profile. 2 source fields
Symbol
STXS
Shares outstanding
102,146,373 shares
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
SCHEDULE 13D/A
Accepted by SEC
12 Nov 2026, 17:00:14 UTC
Event date
09 Nov 2026
Source filing
View source filing
Filing notes and source

Key filing fact

DAFNA Capital Management LLC disclosed 15% ownership in Stereotaxis, Inc. Common Stock, par value $0.001 per share (STXS) on 09 Nov 2026.

Key facts

  • DAFNA Capital Management LLC filed SCHEDULE 13D/A for Stereotaxis, Inc. Common Stock, par value $0.001 per share (STXS).
  • Disclosed ownership: 15%.
  • Date of event: 09 Nov 2026.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 12 Nov 2026, 17:00.

Research use

  • This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
  • Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

View source filing

Reporting persons

Disclosed reporting parties (5)

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares owned Sole voting power Shared voting power Signature Title CIK
DAFNA Capital Management, LLC 15% 15,333,446 0 15,333,446 /s/ Nathan Fischel Chief Executive Officer 0001389933
Dr. Nathan Fischel 15% 15,628,395 294,949 15,333,446 /s/ Nathan Fischel Nathan Fischel 0001389932
Dr. Fariba Ghodsian 15% 15,333,446 0 15,333,446 /s/ Fariba Ghodsian Fariba Ghodsian 0001733969
DAFNA LifeScience, L.P. 7.9% 8,005,938 0 8,005,938 /s/ Nathan Fischel Chief Executive Officer of DAFNA Capital Management, LLC, general partner of DAFNA LifeScience, L.P.
DAFNA LifeScience Select, L.P. 7.3% 7,327,508 0 7,327,508 /s/ Nathan Fischel Chief Executive Officer of DAFNA Capital Management, LLC, general partner of DAFNA LifeScience Select, L.P.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .